David Pope, PharmD, Chief Pharmacy Officer at XiFin, joined Drug Topics to discuss value-based care and how it has changed the way pharmacy operates.
While some experts believe value-based care is a model of the future in pharmacy, others—like David Pope, PharmD, Chief Pharmacy Officer at XiFin—believe it’s how pharmacy has always operated. But amongst declining reimbursements and burnout in the workforce, pharmacists have had an evolving relationship with providing value-based care.
According to the Centers for Medicare & Medicaid Services, value-based care focuses on the quality and performance of a health care providers’ medical services, making the patient’s experience the forefront of how care is delivered.1 Most pharmacists will say that their patients are always at the forefront of what they do. However, amidst pharmacy benefit manager (PBM) tactics that industry experts believe are taking away from the profits of pharmacies nationwide, value-based care is getting more difficult to facilitate.
In the most recent episode of Over the Counter, David Pope joined Drug Topics to discuss the idea of value-based care within pharmacies, where the pressure of PBMs comes into play, and how his company XiFin is working hand in hand with pharmacists across the country.
READ MORE: Q&A: Why Value-Based Care Can Lead to Increased Revenue in the Pharmacy
Pharmacy practice is always changing. Stay ahead of the curve: Sign up for our free Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips, straight to your inbox.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.